A group of pension funds has told pharmaceutical firms they need more information about the industry's emerging market strategies
The £22bn Universities Superannuation Scheme and the €175bn APG Investments - which administers government and educational scheme investments in the Netherlands - said long-term investment opportun...
To continue reading this article...
Join Professional Pensions
Signup and gain exclusive members-only insights
- Unlimited access to real-time news, analysis and opinion from the industry
- Receive our in-depth monthly magazine in either print or digital format
- Access our Sustainable Investment Hub covering news and opinion from thought leaders in the ESG space
- Receive important and breaking news stories selected by the Editors in our daily newsletter
- Hear from industry experts and other forward-thinking leaders
- Receive a monthly members-only newsletter with exclusive opinion pieces from leading industry experts and a feature from the magazine in advance of its release date
